Intellia Therapeutics (NTLA) PT Lowered to $80 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $12.47 --0%
Rating Summary:
22 Buy, 9 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 15 | New: 8
Rating Summary:
22 Buy, 9 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 15 | New: 8
Join SI Premium – FREE
Stifel analyst Dae Gon Ha lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $80.00 (from $93.00) while maintaining a Buy rating.
You May Also Be Interested In
- Capgemini SE (CAP:FP) (CAPMF) PT Raised to EUR160 at BofA Securities
- World Kinect (WKC) PT Lowered to $39 at BofA Securities
- Fortrea (FTRE) PT Raised to $26 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
